Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.
Affiliation
CRC Department of Medical Oncology, Christie and Wythenshawe Hospitals, Manchester, England.Issue Date
1997-06
Metadata
Show full item recordAbstract
Recent studies have indicated that chemotherapy not only provides some survival benefit, but also reduces tumor-related symptoms and improves the performance status of patients receiving chemotherapy. Data from single-agent gemcitabine studies demonstrate improvements in a range of tumor symptoms, including cough, hemoptysis, pain, dyspnea, and anorexia, as well as increases in performance status. Indeed, more patients benefit from gemcitabine chemotherapy than suggested by the objective response rate. Surveys also have shown that patients are much more likely to accept chemotherapy for what is perceived by health care professionals as potentially small benefits. Gemcitabine has a role in the palliative treatment of patients with advanced non-small cell lung cancer.Citation
Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer. 1997, 24 (3 Suppl 8):S8-6-S8-12 Semin. Oncol.Journal
Seminars in OncologyPubMed ID
9207309Type
ArticleLanguage
enISSN
0093-7754Collections
Related articles
- Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms.
- Authors: Thatcher N, Anderson H, Betticher DC, Ranson M
- Issue date: 1995 Dec
- The emerging role of gemcitabine in lung cancer: part I.
- Authors: Bunn PA Jr
- Issue date: 1997 Apr
- Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
- Authors: Hansen HH, Sørensen JB
- Issue date: 1997 Apr
- Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
- Authors: Neubauer MA, Reynolds CH, Joppert MG, Whitaker T, Ghaddar H, Marsland TA, Asmar L
- Issue date: 2005 Jan
- The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
- Authors: Evans WK, Kocha W, Gagliardi A, Eady A, Newman TE
- Issue date: 1999 Feb